Tempest Therapeutics's total assets for Q3 2025 were $17.13M, a decrease of -30.04% from the previous quarter. TPST total liabilities were $10.78M for the fiscal quarter, a -26.65% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.